国际标准期刊号: 2161-119X

耳鼻喉科:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Analysis of the Anesthesia Effects of Otolaryngology Surgery with Cisatracurium Besylate and Mivacurium Chloride

Archana Varman

The goal is to compare and contrast the anaesthetic effects of otolaryngology surgery using cisatracurium besylate and mivacurium chloride. For a retrospective analysis, 108 patients who underwent ENT surgery in our hospital between November 2021 and March 2022 were selected. Patients in the experimental group A were given cisatracurium besylate, while patients in the experimental group B were given mivacurium. The anaesthetic effects and recovery of the two groups were then compared and analysed. At the six time periods of admission, anaesthetic induction, intubation, end of procedure, recovery of consciousness, and extubation, there was no statistically significant difference in mean arterial pressure, heart rate, or pulse oximetry levels between the two groups.

Extubation, recuperation after surgery, and the train of four stimulation levels were all considerably greater than they were for experimental group A. The experimental group B experienced much shorter recovery times for self-consciousness, extubation, and eye opening than the experimental group A, and experienced significantly less agitation than the experimental group A. The overall incidence of unfavourable conditions was substantially lower in experimental group B than it was in experimental group A. Mivacurium chloride anaesthesia presents a viable alternative to cisatracurium besylate in otolaryngology surgery in terms of reduced hemodynamic impact, quicker postoperative recovery, lack of the build-up of neuromuscular blockade, less unpleasant responses, and higher safety.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。